JUPW simply Acquired a 3 Million Greenback Agency and Began a 5 Million Greenback Share Buyback. JUPW has been Featured on CNN, ABC, CBS, Bloomberg, Vogue & Forbes
– Developer of CBD Primarily based Remedies for A number of Pores and skin Care Purposes.
– New e-Commerce & Advertising Workforce with Skilled Business Veterans.
– JW-300 Therapy Demonstrated Efficacy for Growing Burns (sunburn) in Scientific Trial.
– Acquisition of Ascent Scientific Analysis Including $3 Million Annual Income Plus EBITDA Contribution.
– Unique Worldwide Rights to Patented Shark Repellent Applied sciences.
– Novel Cannabidiol Aspartame Mixture Therapy Considerably Reduces ISGA Rating in Atopic Dermatitis.
– Unique Worldwide Rights for Distinctive Formulation Addressing Jellyfish and Man O’ Conflict Stings, Sea Lice, and Swimmer’s Itch with 4 Patents-Pending.
– Scientific Trial of JW-200 for the Therapy of Actinic Keratosis.
– $5.0 Million Share Buyback Program.
Breaking Information:
JUPW introduced introduced the acquisition and retirement of two,433,894 frequent shares, which reduces the Firm’s excellent frequent shares to 22,151,528, an approximate 10% discount in shares excellent.
The Firm beforehand introduced a $5.0 million share buyback program. Beneath this system, shares of the Firm’s inventory could also be repurchased periodically within the open market or privately negotiated transactions. To this point, the Firm has bought 2,433,894 beneath this system.
“We proceed to imagine our inventory is undervalued and as we speak’s announcement exhibits continued dedication to our shareholders and the will to retire shares at present market costs. Given our present money place, I strongly really feel this program is a sexy use of capital as we proceed to reposition ourselves for the expansion forward,” stated Brian John CEO.
About JUPW:
Jupiter Wellness, Inc. (NASDAQ: JUPW) is a number one developer of cannabidiol (CBD) primarily based medical therapeutics and wellness merchandise. The JUPW medical pipeline of prescription CBD-enhanced skincare therapeutics deal with indications together with eczema, burns, herpes chilly sores, and pores and skin most cancers. JUPW generates revenues from a rising line of proprietary over-the-counter skincare merchandise together with its flagship CaniSun™ sunscreen and different wellness manufacturers. JUPW has constructed a portfolio of award-winning wellness manufacturers together with CaniSun, fitCBD, Jack, Wellness CBD 1937, Black Belt CBD, and Felix Ambrosia, as effectively prescription therapeutics similar to Photosil which were featured in quite a few media retailers together with the Right this moment Present, CNN, ABC, CBS, Animal Planet, AdWeek, Bloomberg, The Washington Publish, Vogue, BuzzFeed, and Forbes. As JUPW continues to increase its clinically examined, science-backed wellness, over-the-counter, and prescription product pipeline, the brand new advertising and marketing crew is about to drive revenues
JUPW has offered its JW-300, a cannabidiol topical therapy for first diploma burns, at SCALE 2022 Aesthetic Drugs, Plastic Surgical procedure & Medical Dermatology Convention held Could 11-15, 2022 in Nashville.
The outcomes display JW-300’s potential as both a prescription or over-the-counter topical cream to assist stop sunburn and its penalties together with pores and skin most cancers.
On April twenty seventh JUPW introduced it has concluded an Asset Buy Settlement with Ascent Scientific Analysis, Inc. by which it has acquired sure medical belongings together with medical trial analysis contracts price $3 million in annual revenues for a purchase order worth of 5% royalties on future web revenues generated by the belongings. This asset buy settlement provides quick revenues to JUPW in Q2 2022 and contributes positively in direction of EBITDA with no upfront money or inventory acquisition value.
View Discovery Channel Movies on the Shark Repellent Know-how Right here: https://youtu.be/Hqp04gdAXyk and Right here: https://youtu.be/PM0YTlbx1qg
On April seventh JUPW introduced the upcoming launch of CaniSun for Shark Protection™, the newest addition to the Firm’s reef-friendly sunscreen line. By a licensing settlement with Shark Protection Applied sciences LLC, the main researcher of chemical, electrochemical, and magnetic shark repellents, JUPW has the unique worldwide rights to patents, formulation, and manufacturing strategies for shark repellent applied sciences to be used in solar and skincare merchandise.
On April sixth JUPW introduced the publication of medical examine outcomes to analyze the security and efficacy of JW-100, its proprietary lotion formulation for the therapy of atopic dermatitis (eczema) within the Journal of Beauty Dermatology, Vol. 21, Subject 4, April 2022, pp: 1647-1650.
On April fifth JUPW introduced the launch of NoStingz, a proprietary line of sunscreen designed to guard in opposition to jellyfish and man o’ battle stings, sea lice, and swimmer’s itch all whereas persevering with to guard ocean lovers’ pores and skin from UVA/UVB in a variety of SPFs. JUPW has signed a license settlement with Shark Protection Applied sciences for the unique worldwide mental property rights to formulation and manufacturing strategies for jellyfish protecting compounds together with 4 patents pending. The settlement consists of future collaboration to develop and refine extra formulation.
For extra on The JUPW NoStingz product or to buy go to: https://canisun.com/store/nostingz-your-barrier-of-protection-from-sun-sea/
On February 18th JUPW introduced it has accomplished recruitment in its medical trial of JW-200 for the therapy of actinic keratosis (AK), a standard type of pre-cancerous growths that sometimes current as thick scaly lesions on solar uncovered pores and skin. If left untreated, as much as 15.1% of sufferers with 10 or extra AK lesions will develop keratinocyte carcinoma.
On January twenty fifth JUPW introduced it its board of administrators authorized a $5.0 million share buyback program which expires on June 30, 2022. Beneath the Share Buyback Program, shares of JUPW frequent inventory could also be repurchased periodically in open market or privately negotiated transactions.
For added info on Jupiter Wellness, Inc. (JUPW) go to www.jupiterwellnessinc.com. or https://markets.financialcontent.com/streetinsider/article/getnews-2022-6-3-jupiter-wellness-jupw-to-offer-clinical-research-services-with-acquisition-of-ascent-clinical-research/
DISCLAIMER: The merchandise talked about are THC-free and/or compliant with the 2018 Farm Invoice.
This text is solely for informational functions and isn’t a suggestion in any manner for purchasing or promoting shares
Media Contact
Firm Identify: Jupiter Wellness, Inc
Contact Individual: Brian John, CEO
Electronic mail: Ship Electronic mail
Cellphone: 561 244 7100
Deal with:725 North Freeway A1A Suite C-106
Metropolis: Jupiter
State: FL 33477
Nation: United States
Web site: https://jupiterwellness.com/jupiter-wellness-inc-nasdaq-jupw-is-set-to-offer-clinical-research-services-with-the-3-million-dollar-acquisition-of-acquired-ascent-clinical-research/
